Semaglutide is mostly well tolerated with similar dropout rates in comparison with placebo, even though it can be considerably less properly tolerated than dulaglutide (Trulicity).one,3 The most typical adverse results are nausea, vomiting, and diarrhea and can be seasoned by about thirty% of patients, usually when the dose is greater.Formulated by